Daxor Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,087.30
2,892.70
5,934.40
668.00
1,461.10
1,307.70
Pretax Income
11,980.50
4,506.90
7,880.70
1,467.40
1,215.30
1,218.30
Consolidated Net Income
8,218.40
976.70
9,146.40
1,455.80
1,239.90
885.80
Net Income
8,218.40
976.70
9,146.40
1,455.80
1,239.90
885.80
Net Income After Extraordinaries
8,218.40
976.70
9,146.40
1,455.80
1,239.90
885.80
Net Income Available to Common
8,218.40
976.70
9,146.40
1,455.80
1,239.90
885.80
EPS (Basic)
2.01
0.24
2.37
0.38
0.33
0.24
Basic Shares Outstanding
4,089.60
3,990.90
3,852.50
3,825.50
3,767.80
3,742
EPS (Diluted)
2.01
0.24
2.37
0.38
0.33
0.24
Diluted Shares Outstanding
4,089.60
3,990.90
3,852.50
3,825.50
3,767.80
3,742
Total Expense
6,893.20
1,614.30
13,815.10
799.30
245.80
89.30
Operating Income
11,980.50
4,506.90
7,880.70
1,467.40
1,215.30
1,218.30
Income Taxes
3,762.10
3,530.20
1,265.70
11.60
24.60
332.60

About Daxor

View Profile
Address
Empire State Building
New York New York 10118
United States
Employees -
Website http://www.daxor.com
Updated 07/08/2019
Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.